2010/12/04 by Gideon Koren, Michael Lishner · 1 citation
Medicine · #Pregnancy and Medication Impact #Pregnancy and preeclampsia studies #Neurological Complications and Syndromes
paper · pdf · doi:10.1182/asheducation-2010.1.160
openalex publication_date 2010/12/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/11
When a woman suffering from a hematological condition is contemplating pregnancy, she may need to continue the use of medications that do not have sufficient evidence of fetal safety. We discuss the evidence existing for some therapies of major hematological conditions in the context of major principles in clinical teratology. It is critical to always balance the potential fetal risks of the drug in question against the maternal and fetal risks of the untreated hematological condition.